Advanced Medical Equipment & Technology

ifa systems AG gives FY 2014 outlook

ifa systems AG:Expects for FY 2014 growth in overall performance by about 5 pct and EBIT increase of about 15 pct.

2:42am EDT

Luminex Corp reaffirms FY 2014 revenue guidance

Luminex Corp:Reaffirms FY 2014 annual revenue guidance of between $225 mln and $240 mln.FY 2014 revenue of $231 mln - Thomson Reuters I/B/E/S.

Monday, 28 Jul 2014 04:05pm EDT

GenMark Diagnostics Inc gives Q2 2014 guidance above analysts' estimates

GenMark Diagnostics Inc:Expects Q2 2014 revenue of $6.6 mln.Q2 2014 revenue of $4.8 mln - Thomson Reuters I/B/E/S.

Monday, 28 Jul 2014 04:05pm EDT

Quidel receives FDA clearance for Hand-Held Molecular Diagnostic Test for Group A Strep

Quidel Corp:Receives clearance from United States Food and Drug Administration (FDA).To market AmpliVue GAS Assay for qualitative detection of Group A -hemolytic Streptococcus (Streptococcus pyogenes) nucleic acids isolated from throat swab specimens obtained from patients with signs and symptoms of...

Monday, 28 Jul 2014 09:00am EDT

Mergers & Acquisitions

Expansion & New Markets

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.

Analyst Research

Report Title Price
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.